Showing 1241-1250 of 7550 results for "".
Viewpoints : Too Many People with Dermatologic Diseases Are Excluded from Drug Innovation. Let’s Change Thathttps://practicaldermatology.com/topics/psoriasis/iviewpointsi-too-many-people-with-dermatologic-diseases-are-excluded-from-drug-innovation-lets-change-that/23713/The Role for Rinvoq in AD Care
https://practicaldermatology.com/topics/atopic-dermatitis/the-role-for-rinvoq-in-ad-care/23663/One of the first oral JAK inhibitors approved in dermatology expands options for moderate to severe AD.Long-term efficacy and safety data from ILUMYA™ clinical trials
https://practicaldermatology.com/topics/psoriasis/long-term-efficacy-and-safety-data-from-ilumya-clinical-trials/19858/Explore efficacy and safety data for ILUMYA™ from the reSURFACE 1 and reSURFACE 2 Phase 3 trials and extension studies.Currents
https://practicaldermatology.com/topics/practice-management/currents-7/23346/UCB: Committed to Driving Immuno-dermatology Forward
https://practicaldermatology.com/topics/psoriasis/ucb-committed-to-driving-immuno-dermatology-forward/23327/What You Should Know About Antibody Testing for SARS-CoV-2
https://practicaldermatology.com/topics/infections-infectious-disease/what-you-should-know-about-antibody-testing-for-sars-cov-2/23297/Here’s what we know about testing and its potential role for practices.Currents: Dermatology Forges Ahead
https://practicaldermatology.com/topics/practice-management/currents-dermatology-forges-ahead/23294/Six Financial Actions to Take During the COVID-19 Crisis
https://practicaldermatology.com/topics/practice-management/six-financial-actions-to-take-during-the-covid-19-crisis/23293/Tips to help weather the storm and prepare for better days ahead.Currents: Caring For Acne and Rosacea In the Era of COVID-19 and Beyond
https://practicaldermatology.com/topics/acne-rosacea/currents-caring-for-acne-and-rosacea-in-the-era-of-covid-19-and-beyond/23276/Close Up: Exploring New Research in Metastatic Melanoma
https://practicaldermatology.com/topics/skin-cancer-photoprotection/close-up-exploring-new-research-in-metastatic-melanoma/19673/Adil Daud, MD discusses the promising results of a new study looking at the use of Tafinlar (dabrafenib) and Mekinist (trametinib) in BRAF-mutated advanced melanoma.